Schedule of Parties to OncoGenex Voting Agreements with Sonus Pharmaceuticals, Inc.
This document lists the individuals and entities that are parties to voting agreements with Sonus Pharmaceuticals, Inc. The agreements, referenced in a prior SEC filing, require these parties to vote their shares in a specified manner, likely in connection with a corporate action involving OncoGenex. The listed parties include investment funds, corporations, and individuals. The schedule itself does not detail the terms of the agreements but identifies who is bound by them.
EXHIBIT 10.1.1
SCHEDULE OF PARTIES TO ONCOGENEX VOTING AGREEMENTS
Each of the individuals identified below is party to a voting agreement with Sonus Pharmaceuticals, Inc. in the form filed as Exhibit 10.1 to Sonus’ Current Report on Form 8-K filed with the Securities and Exchange Commission on May 30, 2008:
Ventures West 7 Limited Partnership
Ventures West 7 U.S. Limited Partnership
H.I.G. Horizon Corp.
Working Opportunity Fund (EVCC) Ltd.
BDC Capital Inc.
Business Development Bank of Canada
Milestone Medica Corporation
Sherry Tryssenaar
Vancouver Prostate Research Foundation
Quest/BC Advantage Funds
WHI Morula Fund, LLC
Scott Cormack
Martin Gleave
603356 B.C. Ltd.
Steve Anderson
Cindy Jacobs
Neil Clendeninn
Tom Bailey
